Aquestive Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BRATTON CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 9.81 M | $28.45 M | 0.00% | 10.27% |
BLACKROCK, INC. | 05/02/2025 | 5.94 M | $17.21 M | -1.05% | 6.22% |
VANGUARD GROUP INC | 05/09/2025 | 4.07 M | $11.81 M | -6.29% | 4.27% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 3.73 M | $10.81 M | 100.00% | 3.90% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.70 M | $4.93 M | 2.79% | 1.78% |
MORGAN STANLEY | 05/15/2025 | 1.53 M | $4.43 M | 107.26% | 1.60% |
STATE STREET CORP | 05/15/2025 | 1.52 M | $4.42 M | 1.25% | 1.59% |
PALE FIRE CAPITAL SE | 05/14/2025 | 1.34 M | $3.87 M | 154.05% | 1.40% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.33 M | $3.86 M | 92.75% | 1.39% |
JANNEY MONTGOMERY SCOTT LLC | 04/17/2025 | 1.06 M | $3.07 M | 7.65% | 1.11% |
BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 920.00 K | $2.67 M | 2.22% | 0.96% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 818.85 K | $2.37 M | -6.58% | 0.86% |
NORTHERN TRUST CORP | 05/13/2025 | 587.83 K | $1.70 M | -2.00% | 0.62% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 576.40 K | $1.67 M | 3,502.50% | 0.60% |
HARVEY CAPITAL MANAGEMENT INC | 04/30/2025 | 499.57 K | $1.45 M | 86.83% | 0.52% |
CITADEL ADVISORS LLC | 05/15/2025 | 459.55 K | $1.33 M | 20.40% | 0.48% |
BRACEBRIDGE CAPITAL, LLC | 05/15/2025 | 459.22 K | $1.33 M | 0.00% | 0.48% |
WOODLINE PARTNERS LP | 05/15/2025 | 407.66 K | $1.18 M | -0.40% | 0.43% |
SIO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 391.63 K | $1.14 M | 100.00% | 0.41% |
STIFEL FINANCIAL CORP | 05/14/2025 | 375.13 K | $1.09 M | -5.88% | 0.39% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 372.06 K | $1.08 M | 111.46% | 0.39% |
UBS GROUP AG | 05/13/2025 | 314.33 K | $911.55 K | -25.26% | 0.33% |
05/16/2025 | 300.00 K | $870.00 K | 38.75% | 0.31% | |
JPMORGAN CHASE & CO | 05/12/2025 | 298.02 K | $864.25 K | 294.72% | 0.31% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 285.64 K | $828.36 K | 47.33% | 0.30% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 258.22 K | $748.83 K | 196.03% | 0.27% |
LATASH INVESTMENTS, LLC | 05/13/2025 | 243.13 K | $705.09 K | 0.00% | 0.25% |
05/12/2025 | 236.47 K | $685.77 K | 100.00% | 0.25% | |
CAHILL WEALTH MANAGEMENT, LLC | 05/12/2025 | 218.38 K | $633.31 K | 52.66% | 0.23% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 210.70 K | $611.03 K | 0.01% | 0.22% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 205.54 K | $596.08 K | 14.44% | 0.22% |
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 200.00 K | $3.04 M | 25.00% | 0.21% |
ENTRYPOINT CAPITAL, LLC | 05/14/2025 | 192.76 K | $558.99 K | 41.94% | 0.20% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2025 | 189.18 K | $549.00 K | 160.91% | 0.20% |
D. E. SHAW & CO., INC. | 05/15/2025 | 179.04 K | $519.20 K | 41.57% | 0.19% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 176.26 K | $511.15 K | 8.50% | 0.18% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 168.89 K | $489.77 K | -1.63% | 0.18% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 167.70 K | $486.33 K | 100.00% | 0.18% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 142.00 K | $411.80 K | 11.81% | 0.15% |
CITADEL ADVISORS LLC | 05/15/2025 | 136.60 K | $396.14 K | 108.55% | 0.14% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 129.02 K | $374.16 K | 12.20% | 0.14% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 125.50 K | $363.94 K | 15.65% | 0.13% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 108.66 K | $315.12 K | 36.45% | 0.11% |
RHUMBLINE ADVISERS | 05/29/2025 | 104.36 K | $302.65 K | -2.43% | 0.11% |
05/07/2025 | 91.54 K | $265.47 K | 100.00% | 0.10% | |
PENN CAPITAL MANAGEMENT COMPANY, LLC | 05/14/2025 | 86.62 K | $251.19 K | 100.00% | 0.09% |
CREATIVE PLANNING | 05/15/2025 | 85.62 K | $248.30 K | 13.62% | 0.09% |
BARCLAYS PLC | 05/15/2025 | 82.96 K | $241.00 K | -30.12% | 0.09% |
XTX TOPCO LTD | 05/08/2025 | 78.52 K | $227.71 K | 100.00% | 0.08% |
AQUATIC CAPITAL MANAGEMENT LLC | 05/15/2025 | 64.91 K | $188.24 K | 3.67% | 0.07% |
Aquestive Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 151 institutional investors and hedge funds held shares of Aquestive Therapeutics, Inc.. The most heavily invested institutionals were:
Bratton Capital Management, L.P.: 9.81 M
BlackRock, Inc.: 5.94 M
VANGUARD GROUP INC: 4.07 M
PERCEPTIVE ADVISORS LLC: 3.73 M
GEODE CAPITAL MANAGEMENT, LLC: 1.7 M
MORGAN STANLEY: 1.53 M
46.34% of Aquestive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 50.20 M shares in the last 24 months. This purchase volume represents approximately $186.74 M in transactions.